134 related articles for article (PubMed ID: 118835)
21. [Report of the 3d International Conference on the immunology of meningococcal meningitis. Current status of meningococcus B vaccine].
Del Real G
Rev Sanid Hig Publica (Madr); 1979; 53(11-12):1639-49. PubMed ID: 45419
[No Abstract] [Full Text] [Related]
22. Measurement of growth-inhibiting (bactericidal) antibodies in patients with meningococcal meningitis and in subjects immunized with meningococcal polysaccharide vaccine by a [3H]thymidine assay.
Hassan-King M; Greenwood BM; Whittle HC
J Clin Microbiol; 1985 Jul; 22(1):136-8. PubMed ID: 3926814
[TBL] [Abstract][Full Text] [Related]
23. Meningococcal vaccines in prevention and control of meningitis.
Saxena SN; Rawal IJ; Tripathi KK; Gupta P
Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978
[No Abstract] [Full Text] [Related]
24. Susceptibility to meningococcal meningitis.
Sabath LD; Rosner B
N Engl J Med; 1973 May; 288(22):1185. PubMed ID: 4633552
[No Abstract] [Full Text] [Related]
25. [Status of cellular immunity in viral, serous and meningococcal meningitis].
Zaplotnaia AA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):39-41. PubMed ID: 1326171
[TBL] [Abstract][Full Text] [Related]
26. Meningococci.
Sippel JE
Crit Rev Microbiol; 1981; 8(3):267-302. PubMed ID: 6781818
[No Abstract] [Full Text] [Related]
27. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.
Herva E; Leinonen M; Käyhty H; Mäkelä PH; Vetoniemi-Korhonen SL
J Infect; 1983 Jan; 6(1):55-60. PubMed ID: 6411822
[TBL] [Abstract][Full Text] [Related]
28. Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. II. Immune specificity of antimeningococcal activity.
Smith LF; Lowell GH
J Infect Dis; 1980 Jun; 141(6):748-51. PubMed ID: 6771337
[TBL] [Abstract][Full Text] [Related]
29. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.
Käyhty H; Karanko V; Peltola H; Sarna S; Mäkelä PH
J Infect Dis; 1980 Dec; 142(6):861-8. PubMed ID: 6780634
[TBL] [Abstract][Full Text] [Related]
30. [Immune response to anti-meningococcal vaccines].
Milagres LG; Melles CE
Rev Saude Publica; 1993 Jun; 27(3):221-6. PubMed ID: 8115838
[TBL] [Abstract][Full Text] [Related]
31. Evidence for familial immune defect in meningococcal meningitis.
Whittle HC; Oduloju A; Evans-Jones G; Greenwood BM
Br Med J; 1976 May; 1(6020):1247-50. PubMed ID: 817771
[TBL] [Abstract][Full Text] [Related]
32. [Relationship of eicosanoids to cellular and humoral immunity factors in meningococcal infection].
Pokrovskiĭ VI; Rezhabek AE
Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):63-8. PubMed ID: 2496543
[TBL] [Abstract][Full Text] [Related]
33. Relationship of dose to the reactogenicity and immunogenicity of meningococcal polysaccharide vaccines in adults.
Griffiss JM; Brandt BL; Broud DD; Altieri PL; Berman SL
Mil Med; 1985 Oct; 150(10):529-33. PubMed ID: 3934585
[No Abstract] [Full Text] [Related]
34. Crossed immunoelectrophoretic analysis of Neisseria meningitidis antigens and of corresponding antibodies in patients with meningococcal disease.
Hoff GE; Høiby N
Acta Pathol Microbiol Scand C; 1978 Feb; 86(1):1-9. PubMed ID: 81590
[TBL] [Abstract][Full Text] [Related]
35. [Cross-reacting intraspecies antigens of Neisseria meningitidis. II. The dynamics of antimeningococcal antibodies to cross-reacting antigens in different forms of meningococcal infection].
Martynov IuV; Gracheva AM; Samsonova IM; Mol'kova LSh; Petina GK
Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):60-5. PubMed ID: 6084377
[TBL] [Abstract][Full Text] [Related]
36. [Level of rosette-forming cells in patients with meningococcal infections].
Krasnoproshina LI; Bolibrukh TA; Pokrovskiĭ VI; Matveeva SM; Semina NA
Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):56-60. PubMed ID: 6785946
[TBL] [Abstract][Full Text] [Related]
37. An in vitro model to study the effect of antibodies and cell receptor analogues on meningococcal adherence to human oroepithelial cells.
Carbonare SB; Nuñez-Vaca SP; Bajerl P; Honorio AC; Silva ML; Carneiro-Sampaio MM
Braz J Med Biol Res; 1996 Feb; 29(2):239-44. PubMed ID: 8731355
[TBL] [Abstract][Full Text] [Related]
38. Meningococcal molecular mimicry and the search for an ideal vaccine.
Griffiss JM; Yamasaki R; Estabrook M; Kim JJ
Trans R Soc Trop Med Hyg; 1991; 85 Suppl 1():32-6. PubMed ID: 1725072
[TBL] [Abstract][Full Text] [Related]
39. Nature of the antigen present in the cerebrospinal fluid and serum of patients with group A meningococcal meningitis.
Greenwood BM; Whittle HC
Clin Exp Immunol; 1974 Mar; 16(3):413-7. PubMed ID: 4219838
[TBL] [Abstract][Full Text] [Related]
40. [Comparative study of the sensitivity and specificity of dried and liquid meningococcal erythrocyte diagnostic agents A, C and Y in a controlled trial].
Nikitiuk NM; Sumarokov AA; Nefedova LA; Pavlova LI; Kostiukova NN
Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):72-6. PubMed ID: 6435359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
